Arrowroot Family Office’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$672K Sell
2,748
-34
-1% -$7.92K 0.22% 91
2025
Q4
$576K Sell
2,782
-364
-12% -$72K 0.21% 84
2025
Q3
$583K Sell
3,146
-223
-7% -$38.2K 0.23% 82
2025
Q2
$515K Buy
+3,369
New +$518K 0.23% 83
2024
Q4
$476K Buy
3,294
+724
+28% +$112K 0.25% 81
2024
Q3
$416K Buy
2,570
+55
+2% +$8.76K 0.24% 83
2024
Q2
$368K Sell
2,515
-23
-0.9% -$3.42K 0.24% 88
2024
Q1
$402K Sell
2,538
-21
-0.8% -$3.34K 0.26% 85
2023
Q4
$401K Sell
2,559
-35
-1% -$5.37K 0.28% 80
2023
Q3
$404K Sell
2,594
-19
-0.7% -$3.13K 0.32% 77
2023
Q2
$432K Buy
2,613
+639
+32% +$103K 0.33% 77
2023
Q1
$306K Buy
+1,974
New +$319K 0.26% 89

Other funds holding JNJ

Arrowroot Family Office's JNJ Position: Q1 2026 in Review

Arrowroot Family Office reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q1 2026, selling an estimated $7.92K and leaving 2,748 shares worth $672K. The position accounts for 0.22% of the portfolio, ranked #91.

Arrowroot Family Office first reported a position in JNJ in Q1 2023 and has held it in 12 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Arrowroot Family Office held 2,748 shares of Johnson & Johnson worth $672K as of Q1 2026.
  • Arrowroot Family Office sold 34 Johnson & Johnson shares in Q1 2026, an estimated $7.92K.
  • Johnson & Johnson made up 0.22% of Arrowroot Family Office's portfolio in Q1 2026, its #91 holding.
  • Arrowroot Family Office first reported a position in Johnson & Johnson in Q1 2023 and has held it in 12 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Arrowroot Family Office's 13F filing for Q1 2026, filed 14 May 2026.